Biomarker Research

Article	Citations
Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study	175
Development and validation of predictive models combining cell-Free DNA motifs and protein biomarkers for early detection of esophageal squamous cell carcinoma and precancerous lesion	145
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma	125
Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting	122
The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model	122
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients	114
Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis	114
Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer	110
CardioAtlas: deciphering the single-cell transcriptome landscape in cardiovascular tissues and diseases	109
Mitochondrial transfer in hematological malignancies	99
Unraveling the immune microenvironment in primary CNS lymphoma	96
Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma	96
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes	89
Skin-permeable gold nanoparticles with modifications azelamide monoethanolamine ameliorate inflammatory skin diseases	88
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors	86
The overlooked trio: sleep duration, sampling time and physical exercise alter levels of olink-assessed blood biomarkers of cardiovascular risk	84
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology	84
Dynamic changes of bone microarchitecture and volumetric mineral density assessed by HR-pQCT in patients with cervical cancer after concurrent chemoradiotherapy: a prospective study	83
The molecular landscape of the C1498 murine acute myeloid leukemia cell line	83
A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma	83
p53 biology and reactivation for improved therapy in MDS and AML	82
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy	80
Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer	80
tRNA modifications in cancer: from molecular mechanisms to clinical translation	79
Emerging roles of circular RNAs and enhancer RNAs: new insights into the development and management of neurodegenerative disorders	77

miR-22-Galectin-1 as an integral signaling axis in regulating metabolism and immunity in HCC	74
Multi-omics profiling reveals intrathymic triggers and novel biomarkers in thymoma-associated myasthenia gravis	71
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells	70
The formation and function of tertiary lymphoid structures	66
Decoding the microbiome-immune crosstalk in cancer: from mechanisms to therapeutic translation	66
Unveiling the potential of CLL-1: a promising target for AML therapy	65
Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy	63
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends	60
Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease	57
Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions	56
Identification of urinary bacterial genes as biomarkers for non-invasive diagnosis of renal lupus	56
Correction: Manipulation of cancer cell pyroptosis for therapeutic approaches: challenges and opportunities	55
Dysregulation of plasma circulating microRNAs in all-cause and cause-specific cancers: the Rotterdam Study	54
Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics	53
Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development	52
The role and metabolic adaptations of neutrophils in premetastatic niches	52
STAT3–mediated up-regulation of DAB2 via SRC-YAP1 signaling axis promotes Helicobacter pylori-driven gastric tumorigenesis	51
Proteomic and histopathologic profiling reveal molecular features and clinical biomarkers of coronary atherosclerosis	50
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients	50
RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages	50
The role of BATF in immune cell differentiation and autoimmune diseases	49
The involvement of krüppel-like transcription factor 2 in megakaryocytic differentiation induction by phorbol 12-myrestrat 13-acetate	48
Glycochenodeoxycholic acid promotes hepatocarcinogenesis by inducing hepatic progenitor cell differentiation into cancer-associated fibroblasts via sphingosine-1-phosphate receptor 2 signalling	48
Oncogenic ACSM6 impairs CD8+ T cell-based immune response in bladder cancer	48
Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia/lymphoma	47
Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC	47
The methyltransferase-like proteins as core regulators of nucleic acid modifications and post-translation modification of proteins in disease pathogenesis and therapeutic implications	45
BRD4: an effective target for organ fibrosis	45
Correction: Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation	44
Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas	43
Immunophenotypic analysis on circulating T cells for early diagnosis of lung cancer	43
Transcriptomic analysis of transformed small-cell lung cancer from EGFR-mutated lung adenocarcinoma reveals distinct subgroups and precision therapy opportunities	42
Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions	41
Isolation and typing techniques for circulating tumor cells	41
Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma	41
The actively secreted plasma extracellular vesicle troponin (ASPECT) study: circulating troponin in extracellular vesicles across cardiovascular disease cohorts	41
Plasmatic CXCL13 as a biomarker of primary resistance to immunotherapy and impaired peripheral immunity in non-small cell lung cancer	41
Correction: Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation	40
Correction: Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential	40
RBM10 modulation of circRNA biogenesis contributes to its tumor suppressor role in lung adenocarcinoma	39
Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis	38
The cGAS-STING pathway at the crossroads of neuroimmunology: bridging innate immunity to aging and neurodegeneration	38
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis	38
Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as	38
Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis	38
The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study	38
Mega-scale single-cell profiling reveals novel biomarkers associated with acute GvHD after allogeneic hematopoietic stem cell transplantation	38
Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance	37
Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected	37
Updates on CAR T cell therapy in multiple myeloma	37

Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential	37
Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors	37
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients	36
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes	36
High-throughput LDI MS technology decodes the distinct metabolic landscape of prostate cancer in a large-scale cohort	35
Fatty acid metabolism shapes immune responses in chronic lymphocytic leukemia	35
Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer	35
Single-cell RNA sequencing identifies a subtype of FN1 + tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy	34
Analyzing PKC Gamma (+ 19,506 A/G) polymorphism as a promising genetic marker for HCV-induced hepatocellular carcinoma	34
Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives	33
Single-cell sequencing technology in renal cancer: insights into tumor biology and clinical application	33
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer	33
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives	32
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer	32
Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy	32
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer	31
Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery	31
Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers	31
Identification of a miRNAs signature as potential biomarker of mesenchymal phenotype in neuroblastoma patients	31
The importance of critically short telomere in myelodysplastic syndrome	31
New cell sources for CAR-based immunotherapy	30
Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer	30
FGL1 and FGL2: emerging regulators of liver health and disease	30
RNA epigenetic modifications as dynamic biomarkers in cancer: from mechanisms to clinical translation	30
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma	30
Adipose-derived stem cell exosomes: mechanisms and therapeutic potentials in wound healing	30
Targeted protein degradation in hematologic malignancies: clinical progression towards novel therapeutics	30
Extracellular matrix: unlocking new avenues in cancer treatment	30
NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer	29
A plasma 9-microRNA signature for lung cancer early detection: a multicenter analysis	29
Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer	28
Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives	28
Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma	28
ZDHHC5: a pivotal palmitoyltransferase orchestrating signaling networks – unraveling mechanisms and therapeutic horizons	28
Association of CAR-T approval on outcomes in patients with diffuse large B-cell lymphoma at the population level in the United States	27
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia	27
Association between circulating ECM-associated molecules and cardiovascular outcomes in hemodialysis patients: a multicenter prospective cohort study	27
Plasma proteomics uncovers divergent molecular signatures in ischemic stroke and intracerebral hemorrhage	27
Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification	27
Tobacco smoking associates with NF1 mutations exacerbating survival outcomes in gliomas	27
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples	27
METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer	27
EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway	26
T cells in cancer: mechanistic insights and therapeutic advances	26
Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs	26
Targeting TIGIT for cancer immunotherapy: recent advances and future directions	25
USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition	25
Cancer in transition: discovery of tumor-intrinsic transcriptional programs shaping the immune and microenvironmental landscape	25
S100A9 as a potential novel target for experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome	25
Proteolysis-targeting chimera (PROTAC) in cancer: design principles and applications on “undruggable” targets	25
TUG1: a potential endogenous reference gene for long noncoding RNA quantification in blood-based studies	25
Correction: CRISPR/Cas-based CAR-T cells: production and application	24
Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia	23
Single-cell multi-omics analysis identifies SPP1+ macrophages as key drivers of ferroptosis-mediated fibrosis in ligamentum flavum hypertrophy	23
Epigenetic biomarkers of progestin-resistance in endometriosis	23
Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies	22
Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology	22
The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases	22
Toll-like receptor 3: a double-edged sword	22
MiRNAs as potential therapeutic targets and biomarkers for non-traumatic intracerebral hemorrhage	22
Long non-coding RNA PWRN4 associated with post-SVR hepatocellular carcinoma: a genome-wide association study	21
A germline FLT3 variant in aplastic anemia	21
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications	21
Immune cell profiling supports early prediction of sepsis-associated acute kidney disease using a decision tree algorithm	21
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted	21
Comparing fourteen consensus biomarkers of aging: epigenetic pace of aging as the strongest predictor of mortality in BASE-II	21
Piwi-interacting RNA 775 (piR-775) predicts favorable prognosis and regulates cell cycle and DNA damage response pathways in breast cancer	21
Harnessing multi-omics approaches to decipher tumor evolution and improve diagnosis and therapy in lung cancer	21
PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals	21
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression	20
THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer	20
Cervical cancer heterogeneity: a constant battle against viruses and drugs	20
The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer	20
Crosstalk between lactylation and RNA modifications in tumorigenesis: mechanisms and therapeutic implications	20
The significant others of aurora kinase a in cancer: combination is the key	20
Oncogenic alterations in advanced NSCLC: a molecular super-highway	20
Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis	20
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma	20
PCSK9 in T-cell function and the immune response	20
Stratifying high-risk prediabetes clusters using blood-based epigenetic markers	20

Targeted protein degradation for fetal hemoglobin induction: a new paradigm in β-hemoglobinopathy therapy	19
HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma	19
The role of pyroptosis in modulating the tumor immune microenvironment	19
Correction: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma	19
Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease	19
LncRNA AC006064.4–201 serves as a novel molecular marker in alleviating cartilage senescence and protecting against osteoarthritis by destabilizing CDKN1B mRNA via interacting with PTBP1	19
Ribosome profiling: a powerful tool in oncological research	19
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression	19
The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA	18
Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy	18
Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection	18
Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy	18
Single-cell transcriptomic mapping of immune heterogeneity across angioimmunoblastic T-cell lymphoma subtypes	18
MACC1 revisited – an in-depth review of a master of metastasis	18
Targeted inhibition of Ninjurin2 promotes chemosensitivity in chemoresistant gastric cancer by suppressing cancer-initiating cells	18
Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer	18
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects	18
Peripheral blood biomarkers for predicting response to PD-1/PD-L1 inhibitors	18
Blood and urine biomarkers of disease progression in IgA nephropathy	18
High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort	18
Correction: Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements	17
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling	17
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients	17
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma	17
TRPM channels in human cancers: regulatory mechanism and therapeutic prospects	17
Phenomic landscape and pharmacogenomic implications for HLA region in a Taiwan Han Chinese population	17
Serum interleukin-6 (Il-6) monitoring in idiopathic multicentric Castleman disease: important value in patients receiving non-anti-Il-6 therapy	16
Tumor microenvironment and immunotherapy for triple-negative breast cancer	16
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation	16
Review immune response of targeting CD39 in cancer	16
Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes	16
Histone modification-regulated LncRNA DLEU1 interacts with ASCC2/ALKBH3 complex to drive DNA repair, antioxidant homeostasis and glucose metabolism in gastric cancer	16
Therapeutic landscape of ovarian cancer: recent advances and emerging therapies	16
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia	16
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies	16
Gene therapy for polygenic or complex diseases	15
Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers	15
Detection of circulating tumor cells: opportunities and challenges	15
Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation	15
Circulating tumor DNA for MRD detection in colorectal cancer: recent advances and clinical implications	15
Clinical stabilization of a highly refractory acute myeloid leukaemia under individualized treatment with immune response modifying drugs by in vivo generation of dendritic cells of leukaemic origin (	15
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond	15
CRISPR/Cas-based CAR-T cells: production and application	15
Roles of posttranslational modifications in lipid metabolism and cancer progression	15
Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools	15
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer	15
Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer	15
Global, regional, and national burden of heart failure and its underlying causes, 1990–2021: results from the global burden of disease study 2021	14
Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma	14
Clinical and structural insights into concurrent EGFR and MET exon 14 skipping mutations in NSCLC: a multi-center series	14
Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia	14
LRG1, a novel serum biomarker for iMCD disease activity	14
Correction: A novel 3-miRNA network regulates tumour progression in oral squamous cell carcinoma	14
DeepMPTB: a vaginal microbiome-based deep neural network as artificial intelligence strategy for efficient preterm birth prediction	13
Serum metabolite signatures of cardiac function and morphology in individuals from a population-based cohort	13
Targeting YAP1-CD70 axis potentiates the efficacy of anti-PD-1 therapy in prostate cancer	13
Biomarkers as targets for CAR-T/NK cell therapy in AML	13
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma	13
Development and validation of an integrative 54 biomarker-based risk identification model for multi-cancer in 42,666 individuals: a population-based prospective study to guide advanced screening strat	13
Global surveillance of circulating microRNA for diagnostic and prognostic assessment of acute myocardial infarction based on the plasma small RNA sequencing	13
Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression	13
Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021	13
The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy	13
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma	13
A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia	13
The war between the immune system and the tumor - using immune biomarkers as tracers	13
Inflammation and wound healing: a comprehensive overview of mechanisms, therapeutic strategies, and translational perspectives	13
Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression	13
Untargeted lipidomics reveals racial differences in lipid species among women	13
Combination immunotherapy targeting LAG-3, PD-1 and STING suppresses hepatocellular carcinoma as monitored by LAG-3 targeted PET imaging	13
Multi-omics biomarkers in female fertility: from oocyte quality to endometrial receptivity and clinical translation	12
Advances of cancer-associated fibroblasts in liver cancer	12
Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model	12
Characterization of T-Cell receptor repertoire in immunoglobulin a nephropathy	12
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study	12
Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis	12
Integrating artificial intelligence in drug discovery and early drug development: a transformative approach	12
Advancement in Multi-omics approaches for Uterine Sarcoma	12
Current challenges and best practices for cell-free long RNA biomarker discovery	12
Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML	12
Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues	12
The application of Aptamer in biomarker discovery	12
Molecular network of metabolic reprogramming and precision diagnosis and treatment of hepatocellular carcinoma	12
Bioinformatics tools and data resources for assay development of fluid protein biomarkers	11
Epigenetic signatures on plasma cell-free DNA to detect kidney allograft rejection in a non-invasive way: development of a 10-plex digital PCR assay	11
Single cell spatial profiling of FFPE splenic tissue from a humanized mouse model of HIV infection	11
Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies	11
Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations	11
Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients	11
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective	11
Gene-body DNA methylation of ONECUT2 predicts its expression and prostate cancer aggressiveness in needle biopsies	10
AXL in myeloid malignancies – an elusive target?	10
METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation	10
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases	10
Lectins as potential tools for cancer biomarker discovery from extracellular vesicles	10